Enlisting Monoclonal Antibodies in the Fight Against COVID-19
NIH Director's Blog: Drug Development
MAY 21, 2020
This structural information helps to clarify the precise biochemistry of the complex interaction between SARS-CoV-2 and the antibody, providing a much-needed guide for the rational design of targeted drugs and vaccines. In the U.S. Stay tuned for more information about these potentially significant advances in the next few months.
52 
Let's personalize your content